Compare American Electric Power Company Inc (AEP) vs Boston Scientific Corporation (BSX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Electric Power Company Inc vs Boston Scientific Corporation — how do they compare? American Electric Power Company Inc trades at $123.61 (market cap $67.28B), while Boston Scientific Corporation trades at $51 (market cap $74.19B). The key difference: American Electric Power Company Inc and Boston Scientific Corporation are close in size by market cap, and American Electric Power Company Inc pays a 3.07% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| AEP | BSX | |
|---|---|---|
Market Cap | $67.28B | $74.19B |
Sector | Utilities | Health |
52-Week High | $138.69 | $108.14 |
52-Week Low | $106.44 | $42.63 |
Enterprise Value | $120.17B | $86.27B |
Dividend Yield | 3.07% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Electric Power Company Inc
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →
